Original Articles

You have full text access to this OnlineOpen article

Altered expression of E-cadherin in hepatocellular carcinoma: Correlations with genetic alterations, β-catenin expression, and clinical features

Yu Wei¹,
Jeanne Tran Van Nhieu²,
Sylvie Prigent¹,
Petcharin Srivatanakul³,
Pierre Tiollais¹,
Marie-Annick Buendia^1,*

Article first published online: 30 DEC 2003

DOI: 10.1053/jhep.2002.35342

Issue

Hepatology

Volume 36, Issue 3, pages 692–701, September 2002

Additional Information

How to Cite

Wei, Y., Van Nhieu, J. T., Prigent, S., Srivatanakul, P., Tiollais, P. and Buendia, M.-A. (2002), Altered expression of E-cadherin in hepatocellular carcinoma: Correlations with genetic alterations, β-catenin expression, and clinical features. Hepatology, 36: 692–701. doi: 10.1053/jhep.2002.35342

Author Information

¹
Unité de Recombinaison et Expression Génétique (Inserm U163), Institut Pasteur, Paris
²
Département de Pathologie, Hôpital Henri Mondor, AP-HP, and Université Paris XII, Créteil, France
³
National Cancer Institute, Bangkok, Thailand

Email: Marie-Annick Buendia (mbuendia@pasteur.fr)

^*Unité de Recombinaison et Expression Génétique, Département des Rétrovirus, Institut Pasteur, 28 rue du Dr. Roux, 75724 Paris Cedex 15, France. hyphen;28871, Alcalá de Henares, Spain.fax: (33) 145-68-89-43.

Publication History

Issue published online: 30 DEC 2003
Article first published online: 30 DEC 2003
Manuscript Accepted: 13 JUN 2002
Manuscript Received: 22 MAR 2002

Funded by

Association pour la Recherche sur le Cancer. Grant Number: ARC5236

ARTICLE TOOLS

Abstract
References
Cited By

Get PDF (835K)

References

1
Marchio A, Meddeb M, Pineau P, Danglot G, Tiollais P, Bernheim A, Dejean A. Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization. Genes Chromosomes Cancer 1997; 18:59–65.MEDLINE
Direct Link:
2
Nagai H, Pineau P, Tiollais P, Buendia MA, Dejean A. Comprehensive allelotyping of human hepatocellular carcinoma. Oncogene 1997; 14:2927–2933.MEDLINE
3
Laurent-Puig P, Legoix P, Bluteau O, Belghiti J, Franco D, Binot F, Monges G, et al. Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis. Gastroenterology 2001; 120:1763–1773.MEDLINE
4
Yeh SH, Chen PJ, Shau WY, Chen YW, Lee PH, Chen JT, Chen DS. Chromosomal allelic imbalance evolving from liver cirrhosis to hepatocellular carcinoma. Gastroenterology 2001; 121:699–709.MEDLINE
5
Buendia MA. Genetics of hepatocellular carcinoma. Semin Cancer Biol 2000; 10:185–200.MEDLINE
6
de La Coste A, Romagnolo B, Billuart P, Renard CA, Buendia MA, Soubrane O, Fabre M, et al. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci U S A 1998; 95:8847–8851.MEDLINE
7
Satoh S, Daigo Y, Furukawa Y, Kato T, Miwa N, Nishiwaki T, Kawasoe T, et al. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet 2000; 24:245–250.MEDLINE
8
Tsuda H, Zhang WD, Shimosato Y, Yokota J, Terada M, Sugimura T, Miyamura T, et al. Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc Natl Acad Sci U S A 1990; 87:6791–6794.MEDLINE
9
Piao Z, Park C, Kim JJ, Kim H. Deletion mapping of chromosome 16q in hepatocellular carcinoma. Br J Cancer 1999; 80:850–854.MEDLINE
10
Bando K, Nagai H, Matsumoto S, Koyama M, Kawamura N, Tajiri T, Onda M, et al. Identification of a 1-Mb common region at 16q24.1-24.2 deleted in hepatocellular carcinoma. Genes Chromosomes Cancer 2000; 28:38–44.MEDLINE
Direct Link:
11
Yakicier MC, Legoix P, Vaury C, Gressin L, Tubacher E, Capron F, Bayer J, et al. Identification of homozygous deletions at chromosome 16q23 in Aflatoxin B1 exposed hepatocellular carcinoma. Oncogene 2001; 20:5232–5238.MEDLINE
12
Ihara A, Koizumi H, Hashizume R, Uchikoshi T. Expression of epithelial cadherin and alpha- and beta-catenins in nontumoral livers and hepatocellular carcinoma. Hepatology 1996; 23:1441–1447.MEDLINE
13
Kozyraki R, Scoazec JY, Flejou JF, D'Errico A, Bedossa P, Terris B, Fiorentino M, et al. Expression of cadherins and alpha-catenin in primary epithelial tumors of the liver. Gastroenterology 1996; 110:1137–1149.MEDLINE
14
Kanai Y, Ushijima AM, Ochiai A, Tsuda H, Sakamoto M, Hirohashi S. The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinoma. Int J Cancer 1997; 71:355–359.MEDLINE
Direct Link:
15
Matsumura T, Makino R, Mitamura K. Frequent down-regulation of E-cadherin by genetic and epigenetic changes in the malignant progression of hepatocellular carcinomas. Clin Cancer Res 2001; 7:594–599.MEDLINE
16
Kemler R. From cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesion. Trends Genet 1993; 9:317–321.MEDLINE
17
Chen WC, Obrink B. Cell-cell contacts mediated by E-cadherin (uvomorulin) restrict invasive behavior of L-cells. J Cell Biol 1991; 114:319–327.MEDLINE
18
St Croix B, Sheehan C, Rak JW, Florenes VA, Slingerland JM, Kerbel RS. E-cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIP1). J Cell Biol 1998; 142:557–571.MEDLINE
19
Gottardi CJ, Wong E, Gumbiner BM. E-cadherin suppresses cellular transformation by inhibiting beta-catenin signaling in an adhesion-independent manner. J Cell Biol 2001; 153:1049–1060.MEDLINE
20
Orsulic S, Huber O, Aberle H, Arnold S, Kemler R. E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1-mediated transactivation. J Cell Sci 1999; 112:1237–1245.MEDLINE
21
Sadot E, Simcha I, Shtutman M, Ben-Ze'ev A, Geiger B. Inhibition of beta-catenin-mediated transactivation by cadherin derivatives. Proc Natl Acad Sci U S A 1998; 95:15339–15344.MEDLINE
22
Stockinger A, Eger A, Wolf J, Beug H, Foisner R. E-cadherin regulates cell growth by modulating proliferation-dependent beta-catenin transcriptional activity. J Cell Biol 2001; 154:1185–1196.MEDLINE
23
Berx G, Cleton-Jansen AM, Nollet F, de Leeuw WJ, van de Vijver M, Cornelisse C, van Roy F. E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J 1995; 14:6107–6115.MEDLINE
24
Berx G, Becker KF, Hofler H, van Roy F. Mutations of the human E-cadherin (CDH1) gene. Hum Mutat 1998; 12:226–237.MEDLINE
Direct Link:
25
Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, Baulida J, Garcia De Herreros A. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2000; 2:84–89.MEDLINE
26
Berx G, Roy FV. The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression. Breast Cancer Res 2001; 3:289–293.MEDLINE
27
Graff JR, Gabrielson E, Fujii H, Baylin SB, Herman JG. Methylation patterns of the E-cadherin 5' CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression. J Biol Chem 2000; 275:2727–2732.MEDLINE
28
Bignell GR, Warren W, Seal S, Takahashi M, Rapley E, Barfoot R, Green H, et al. Identification of the familial cylindromatosis tumour-suppressor gene. Nat Genet 2000; 25:160–165.MEDLINE
29
Tomlinson JS, Alpaugh ML, Barsky SH. An intact overexpressed E-cadherin/alpha,beta-catenin axis characterizes the lymphovascular emboli of inflammatory breast carcinoma. Cancer Res 2001; 61:5231–5241.MEDLINE
30
Osada T, Sakamoto M, Ino Y, Iwamatsu A, Matsuno Y, Muto T, Hirohashi S. E-cadherin is involved in the intrahepatic metastasis of hepatocellular carcinoma. Hepatology 1996; 24:1460–1467.MEDLINE
Direct Link:
31
Ishak KG, Anthony PP, Sobin LH. Histological typing of tumors of the liver. In: International Histological Classification of Tumors. 2nd ed. Berlin: Springer-Verlag, 1994; 11–17.
32
Tran van Nhieu J, Renard CA, Wei Y, Cherqui D, Zafrani ES, Buendia MA. Nuclear accumulation of mutated beta-catenin in hepatocellular carcinoma is associated with increased cell proliferation. Am J Pathol 1999; 155:703–710.MEDLINE
33
Baudry D, Jeanpierre C. Assignment of E-cadherin (CDH1) and KSP-cadherin (CDH16) to chromosome 16q22.1 by radiation hybrid mapping. Cytogenet Cell Genet 2000; 88:253–254.MEDLINE
34
Guilford P, Hopkins J, Harraway J, McLeod MNM, Harawira P, Taite H, Scoular R, et al. E-cadherin germline mutations in familial gastric cancer. Nature 1998; 392:402–405.MEDLINE
35
Becker KF, Atkinson MJ, Reich U, Becker I, Nekarda H, Siewert JR, Hofler H. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 1994; 54:3845–3852.MEDLINE
36
Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 1996; 93:9821–9826.MEDLINE
37
Graff JR, Herman JG, Myohanen S, Baylin SB, Vertino PM. Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation. J Biol Chem 1997; 272:22322–22329.MEDLINE
38
Nuruki K, Toyoyama H, Ueno S, Hamanoue M, Tanabe G, Aikou T, Ozawa M. E-cadherin but not N-cadherin expression is correlated with the intracellular distribution of catenins in human hepatocellular carcinomas. Oncol Rep 1998; 5:1109–1114.MEDLINE
39
Mayer B, Johnson JP, Leitl F, Jauch KW, Heiss MM, Schildberg FW, Birchmeier W, et al. E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res 1993; 53:1690–1695.MEDLINE
40
Bindels EM, Vermey M, van den Beemd R, Dinjens WN, Van Der Kwast TH. E-cadherin promotes intraepithelial expansion of bladder carcinoma cells in an in vitro model of carcinoma in situ. Cancer Res 2000; 60:177–183.MEDLINE
41
Huang GT, Lee HS, Chen CH, Sheu JC, Chiou LL, Chen DS. Correlation of E-cadherin expression and recurrence of hepatocellular carcinoma. Hepatogastroenterology 1999; 46:1923–1927.MEDLINE
42
Chen YJ, Yeh SH, Chen JT, Wu CC, Hsu MT, Tsai SF, Chen PJ, et al. Chromosomal changes and clonality relationship between primary and recurrent hepatocellular carcinoma. Gastroenterology 2000; 119:431–440.MEDLINE
43
Yeh SH, Chen PJ, Lai MY, Chen DS. Allelic loss on chromosomes 4q and 16q in hepatocellular carcinoma: association with elevated alpha-fetoprotein production. Gastroenterology 1996; 110:184–192.MEDLINE
44
Gramantieri L, Trere D, Pession A, Piscaglia F, Masi L, Gaiani S, Mazziotti A, et al. Allelic imbalance on 16q in small, unifocal hepatocellular carcinoma: correlation with HBV and HCV infections and cellular proliferation rate. Dig Dis Sci 2000; 45:306–311.MEDLINE
45
Okabe H, Ikai I, Matsuo K, Satoh S, Momoi H, Kamikawa T, Katsura N, et al. Comprehensive allelotype study of hepatocellular carcinoma: potential differences in pathways to hepatocellular carcinoma between hepatitis B virus-positive and -negative tumors. Hepatology 2000; 31:1073–1079.MEDLINE
Direct Link:
46
Graff JR, Herman JG, Lapidus RG, Chopra H, Xu R, Jarrard DF, Isaacs WB, et al. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res 1995; 55:5195–5199.MEDLINE
47
Cheng CW, Wu PE, Yu JC, Huang CS, Yue CT, Wu CW, Shen CY. Mechanisms of inactivation of E-cadherin in breast carcinoma: modification of the two-hit hypothesis of tumor suppressor gene. Oncogene 2001; 20:3814–3823.MEDLINE
48
Davies G, Jiang WG, Mason MD. Matrilysin mediates extracellular cleavage of E-cadherin from prostate cancer cells: a key mechanism in hepatocyte growth factor/scatter factor-induced cell-cell dissociation and in vitro invasion. Clin Cancer Res 2001; 7:3289–3297.MEDLINE
49
Jiao W, Miyazaki K, Kitajima Y. Inverse correlation between E-cadherin and Snail expression in hepatocellular carcinoma cell lines in vitro and in vivo. Br J Cancer 2002; 86:98–101.MEDLINE
50
Fujita Y, Krause G, Scheffner M, Zechner D, Leddy HE, Behrens J, Sommer T, et al. Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex. Nat Cell Biol 2002; 4:222–231.MEDLINE
51
Batsche E, Muchardt C, Behrens J, Hurst HC, Cremisi C. RB and c-Myc activate expression of the E-cadherin gene in epithelial cells through interaction with transcription factor AP-2. Mol Cell Biol 1998; 18:3647–3658.MEDLINE
52
Polakis P. The oncogenic activation of beta-catenin. Curr Opin Genet Dev 1999; 9:15–21.MEDLINE
53
Terris B, Pineau P, Bregeaud L, Valla D, Belghiti J, Tiollais P, Degott C, et al. Close correlation between β-catenin gene alterations and nuclear accumulation of the protein in human hepatocellular carcinomas. Oncogene 1999; 18:6583–6588.MEDLINE

Get PDF (835K)

JOURNAL TOOLS

JOURNAL MENU

FIND ISSUES

FIND ARTICLES

GET ACCESS

FOR CONTRIBUTORS

ABOUT THIS JOURNAL

SPECIAL FEATURES

Altered expression of E-cadherin in hepatocellular carcinoma: Correlations with genetic alterations, β-catenin expression, and clinical features

Hepatology

How to Cite

Author Information

Publication History

Funded by

ARTICLE TOOLS

References

More content like this

JOURNAL TOOLS

JOURNAL MENU

FIND ISSUES

FIND ARTICLES

GET ACCESS

FOR CONTRIBUTORS

ABOUT THIS JOURNAL

SPECIAL FEATURES

Altered expression of E-cadherin in hepatocellular carcinoma: Correlations with genetic alterations, β-catenin expression, and clinical features

Hepatology

How to Cite

Author Information

Publication History

Funded by

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

References

More content like this